Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Sex differences in clinical presentation of systemic lupus erythematosus.

Ramírez Sepúlveda JI, Bolin K, Mofors J, Leonard D, Svenungsson E, Jönsen A, Bengtsson C; DISSECT consortium, Nordmark G, Rantapää Dahlqvist S, Bengtsson AA, Rönnblom L, Sjöwall C, Gunnarsson I, Wahren-Herlenius M.

Biol Sex Differ. 2019 Dec 16;10(1):60. doi: 10.1186/s13293-019-0274-2.

2.

High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus.

Reid S, Alexsson A, Frodlund M, Morris D, Sandling JK, Bolin K, Svenungsson E, Jönsen A, Bengtsson C, Gunnarsson I, Illescas Rodriguez V, Bengtsson A, Arve S, Rantapää-Dahlqvist S, Eloranta ML, Syvänen AC, Sjöwall C, Vyse TJ, Rönnblom L, Leonard D.

Ann Rheum Dis. 2019 Dec 11. pii: annrheumdis-2019-216227. doi: 10.1136/annrheumdis-2019-216227. [Epub ahead of print]

3.

Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus.

Sohrabian A, Parodis I, Carlströmer-Berthén N, Frodlund M, Jönsen A, Zickert A, Sjöwall C, Bengtsson AA, Gunnarsson I, Rönnelid J.

Arthritis Res Ther. 2019 Nov 29;21(1):259. doi: 10.1186/s13075-019-2056-y.

4.

ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus.

Parodis I, Gokaraju S, Zickert A, Vanarsa K, Zhang T, Habazi D, Botto J, Serdoura Alves C, Giannopoulos P, Larsson A, Svenungsson E, Gunnarsson I, Mohan C.

Rheumatology (Oxford). 2019 Nov 13. pii: kez528. doi: 10.1093/rheumatology/kez528. [Epub ahead of print]

PMID:
31722419
5.

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status.

Lyons PA, Peters JE, Alberici F, Liley J, Coulson RMR, Astle W, Baldini C, Bonatti F, Cid MC, Elding H, Emmi G, Epplen J, Guillevin L, Jayne DRW, Jiang T, Gunnarsson I, Lamprecht P, Leslie S, Little MA, Martorana D, Moosig F, Neumann T, Ohlsson S, Quickert S, Ramirez GA, Rewerska B, Schett G, Sinico RA, Szczeklik W, Tesar V, Vukcevic D; European Vasculitis Genetics Consortium, Terrier B, Watts RA, Vaglio A, Holle JU, Wallace C, Smith KGC.

Nat Commun. 2019 Nov 12;10(1):5120. doi: 10.1038/s41467-019-12515-9.

6.

NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus.

Linge P, Arve S, Olsson LM, Leonard D, Sjöwall C, Frodlund M, Gunnarsson I, Svenungsson E, Tydén H, Jönsen A, Kahn R, Johansson Å, Rönnblom L, Holmdahl R, Bengtsson A.

Ann Rheum Dis. 2019 Nov 8. pii: annrheumdis-2019-215820. doi: 10.1136/annrheumdis-2019-215820. [Epub ahead of print]

PMID:
31704719
7.

Comment on: Sudanese and Swedish patients with systemic lupus erythematosus, immunological and clinical comparisons: reply.

Elbagir S, Gunnarsson I, Rönnelid J.

Rheumatology (Oxford). 2019 Oct 18. pii: kez477. doi: 10.1093/rheumatology/kez477. [Epub ahead of print] No abstract available.

PMID:
31624842
8.

Sjögren's syndrome in Systemic Lupus Erythematosus - a subset characterized by a systemic inflammatory state.

Ruacho G, Kvarnström M, Zickert A, Oke V, Rönnelid J, Eketjäll S, Elvin K, Gunnarsson I, Svenungsson E.

J Rheumatol. 2019 Sep 15. pii: jrheum.190250. doi: 10.3899/jrheum.190250. [Epub ahead of print]

9.

Sudanese and Swedish patients with systemic lupus erythematosus: immunological and clinical comparisons.

Elbagir S, Elshafie AI, Elagib EM, Mohammed NA, Aledrissy MIE, Sohrabian A, Nur MAM, Svenungsson E, Gunnarsson I, Rönnelid J.

Rheumatology (Oxford). 2019 Aug 14. pii: kez323. doi: 10.1093/rheumatology/kez323. [Epub ahead of print]

PMID:
31411331
10.

Microparticles Expressing Myeloperoxidase and Complement C3a and C5a as Markers of Renal Involvement in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Antovic A, Mobarrez F, Manojlovic M, Soutari N, De Porta Baggemar V, Nordin A, Bruchfeld A, Vojinovic J, Gunnarsson I.

J Rheumatol. 2019 Aug 1. pii: jrheum.181347. doi: 10.3899/jrheum.181347. [Epub ahead of print]

PMID:
31371653
11.

Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus.

Odqvist L, Jevnikar Z, Riise R, Öberg L, Rhedin M, Leonard D, Yrlid L, Jackson S, Mattsson J, Nanda S, Cohen P, Knebel A, Arthur S, Thörn K, Svenungsson E, Jönsen A, Gunnarsson I, Tandre K, Alexsson A, Kastbom A, Rantapää-Dahlqvist S, Eloranta ML, Syvänen AC, Bengtsson A, Johansson P, Sandling JK, Sjöwall C, Rönnblom L, Collins B, Vaarala O.

Ann Rheum Dis. 2019 Oct;78(10):1363-1370. doi: 10.1136/annrheumdis-2019-215434. Epub 2019 Jul 12.

12.

Circulating Levels of Interferon Regulatory Factor-5 Associates With Subgroups of Systemic Lupus Erythematosus Patients.

Idborg H, Zandian A, Ossipova E, Wigren E, Preger C, Mobarrez F, Checa A, Sohrabian A, Pucholt P, Sandling JK, Fernandes-Cerqueira C, Rönnelid J, Oke V, Grosso G, Kvarnström M, Larsson A, Wheelock CE, Syvänen AC, Rönnblom L, Kultima K, Persson H, Gräslund S, Gunnarsson I, Nilsson P, Svenungsson E, Jakobsson PJ.

Front Immunol. 2019 May 17;10:1029. doi: 10.3389/fimmu.2019.01029. eCollection 2019.

13.

Microparticles in the blood of patients with SLE: Size, content of mitochondria and role in circulating immune complexes.

Mobarrez F, Fuzzi E, Gunnarsson I, Larsson A, Eketjäll S, Pisetsky DS, Svenungsson E.

J Autoimmun. 2019 Aug;102:142-149. doi: 10.1016/j.jaut.2019.05.003. Epub 2019 May 16.

PMID:
31103269
14.

Rapid CO2 mineralisation into calcite at the CarbFix storage site quantified using calcium isotopes.

Pogge von Strandmann PAE, Burton KW, Snæbjörnsdóttir SO, Sigfússon B, Aradóttir ES, Gunnarsson I, Alfredsson HA, Mesfin KG, Oelkers EH, Gislason SR.

Nat Commun. 2019 Apr 30;10(1):1983. doi: 10.1038/s41467-019-10003-8.

15.

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.

Oke V, Gunnarsson I, Dorschner J, Eketjäll S, Zickert A, Niewold TB, Svenungsson E.

Arthritis Res Ther. 2019 Apr 29;21(1):107. doi: 10.1186/s13075-019-1878-y.

16.

Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.

Idborg H, Zandian A, Sandberg AS, Nilsson B, Elvin K, Truedsson L, Sohrabian A, Rönnelid J, Mo J, Grosso G, Kvarnström M, Gunnarsson I, Lehtiö J, Nilsson P, Svenungsson E, Jakobsson PJ.

Arthritis Res Ther. 2019 Feb 18;21(1):62. doi: 10.1186/s13075-019-1836-8.

17.

Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis.

Parodis I, Ding H, Zickert A, Cosson G, Fathima M, Grönwall C, Mohan C, Gunnarsson I.

PLoS One. 2019 Feb 11;14(2):e0212068. doi: 10.1371/journal.pone.0212068. eCollection 2019.

18.

Cytokine Profiles in Autoantibody Defined Subgroups of Systemic Lupus Erythematosus.

Torell F, Eketjäll S, Idborg H, Jakobsson PJ, Gunnarsson I, Svenungsson E, Trygg J.

J Proteome Res. 2019 Mar 1;18(3):1208-1217. doi: 10.1021/acs.jproteome.8b00811. Epub 2019 Feb 18.

PMID:
30742448
19.

Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use.

Sandholm K, Persson B, Skattum L, Eggertsen G, Nyman D, Gunnarsson I, Svenungson E, Nilsson B, Ekdahl KN.

Front Immunol. 2019 Jan 25;10:7. doi: 10.3389/fimmu.2019.00007. eCollection 2019.

20.

Whole-genome sequencing identifies complex contributions to genetic risk by variants in genes causing monogenic systemic lupus erythematosus.

Almlöf JC, Nystedt S, Leonard D, Eloranta ML, Grosso G, Sjöwall C, Bengtsson AA, Jönsen A, Gunnarsson I, Svenungsson E, Rönnblom L, Sandling JK, Syvänen AC.

Hum Genet. 2019 Feb;138(2):141-150. doi: 10.1007/s00439-018-01966-7. Epub 2019 Feb 1.

21.

Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis.

Wilson HR, Medjeral-Thomas NR, Gilmore AC, Trivedi P, Seyb K, Farzaneh-Far R, Gunnarsson I, Zickert A, Cairns TD, Lightstone L, Cook HT, Pickering MC.

Kidney Int. 2019 Mar;95(3):655-665. doi: 10.1016/j.kint.2018.09.027. Epub 2019 Jan 14.

22.

B cell alterations during BAFF inhibition with belimumab in SLE.

Ramsköld D, Parodis I, Lakshmikanth T, Sippl N, Khademi M, Chen Y, Zickert A, Mikeš J, Achour A, Amara K, Piehl F, Brodin P, Gunnarsson I, Malmström V.

EBioMedicine. 2019 Feb;40:517-527. doi: 10.1016/j.ebiom.2018.12.035. Epub 2018 Dec 26.

23.

Clinical SLEDAI-2K zero may be a pragmatic outcome measure in SLE studies.

Parodis I, Emamikia S, Gomez A, Gunnarsson I, van Vollenhoven RF, Chatzidionysiou K.

Expert Opin Biol Ther. 2019 Feb;19(2):157-168. doi: 10.1080/14712598.2019.1561856. Epub 2018 Dec 27.

PMID:
30571926
24.

A rare regulatory variant in the MEF2D gene affects gene regulation and splicing and is associated with a SLE sub-phenotype in Swedish cohorts.

Farias FHG, Dahlqvist J, Kozyrev SV, Leonard D, Wilbe M, Abramov SN, Alexsson A, Pielberg GR, Hansson-Hamlin H, Andersson G, Tandre K, Bengtsson AA, Sjöwall C, Svenungsson E, Gunnarsson I, Rantapää-Dahlqvist S, Syvänen AC, Sandling JK, Eloranta ML, Rönnblom L, Lindblad-Toh K.

Eur J Hum Genet. 2019 Mar;27(3):432-441. doi: 10.1038/s41431-018-0297-x. Epub 2018 Nov 20.

25.

Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.

Frodlund M, Vikerfors A, Grosso G, Skogh T, Wetterö J, Elvin K, Gunnarsson I, Kastbom A, Dahlström Ö, Rönnelid J, Svenungsson E, Sjöwall C.

Clin Exp Immunol. 2018 Oct;194(1):27-38. doi: 10.1111/cei.13180. Epub 2018 Sep 12.

26.

The Impact of Belimumab and Rituximab on Health-Related Quality of Life in Patients With Systemic Lupus Erythematosus.

Parodis I, Lopez Benavides AH, Zickert A, Pettersson S, Möller S, Welin Henriksson E, Voss A, Gunnarsson I.

Arthritis Care Res (Hoboken). 2019 Jun;71(6):811-821. doi: 10.1002/acr.23718.

PMID:
30055091
27.

Smoking reduces the efficacy of belimumab in mucocutaneous lupus.

Parodis I, Gomez A, Frodlund M, Jönsen A, Zickert A, Sjöwall C, Bengtsson AA, Gunnarsson I.

Expert Opin Biol Ther. 2018 Aug;18(8):911-920. doi: 10.1080/14712598.2018.1494719. Epub 2018 Jul 9.

28.

TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus.

Idborg H, Eketjäll S, Pettersson S, Gustafsson JT, Zickert A, Kvarnström M, Oke V, Jakobsson PJ, Gunnarsson I, Svenungsson E.

Lupus Sci Med. 2018 Jun 4;5(1):e000260. doi: 10.1136/lupus-2018-000260. eCollection 2018.

29.

Kynurenine pathway is altered in patients with SLE and associated with severe fatigue.

Åkesson K, Pettersson S, Ståhl S, Surowiec I, Hedenström M, Eketjäll S, Trygg J, Jakobsson PJ, Gunnarsson I, Svenungsson E, Idborg H.

Lupus Sci Med. 2018 May 23;5(1):e000254. doi: 10.1136/lupus-2017-000254. eCollection 2018. Erratum in: Lupus Sci Med. 2019 May 17;6(1):e000254corr1.

30.

Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus - distinct roles of BAFF and APRIL.

Parodis I, Söder F, Faustini F, Kasza Z, Samuelsson I, Zickert A, Svenungsson E, van Vollenhoven RF, Malmström V, Wermeling F, Gunnarsson I.

Lupus. 2018 Aug;27(9):1470-1478. doi: 10.1177/0961203318777116. Epub 2018 May 21.

PMID:
29783918
31.

Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.

Leonard D, Svenungsson E, Dahlqvist J, Alexsson A, Ärlestig L, Taylor KE, Sandling JK, Bengtsson C, Frodlund M, Jönsen A, Eketjäll S, Jensen-Urstad K, Gunnarsson I, Sjöwall C, Bengtsson AA, Eloranta ML, Syvänen AC, Rantapää-Dahlqvist S, Criswell LA, Rönnblom L.

Ann Rheum Dis. 2018 Jul;77(7):1063-1069. doi: 10.1136/annrheumdis-2017-212614. Epub 2018 Mar 7.

32.

Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.

Hardt U, Larsson A, Gunnarsson I, Clancy RM, Petri M, Buyon JP, Silverman GJ, Svenungsson E, Grönwall C.

Arthritis Res Ther. 2018 Feb 26;20(1):36. doi: 10.1186/s13075-018-1530-2.

33.

DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus.

Imgenberg-Kreuz J, Carlsson Almlöf J, Leonard D, Alexsson A, Nordmark G, Eloranta ML, Rantapää-Dahlqvist S, Bengtsson AA, Jönsen A, Padyukov L, Gunnarsson I, Svenungsson E, Sjöwall C, Rönnblom L, Syvänen AC, Sandling JK.

Ann Rheum Dis. 2018 May;77(5):736-743. doi: 10.1136/annrheumdis-2017-212379. Epub 2018 Feb 1.

34.

Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis.

Wigren M, Svenungsson E, Mattisson IY, Gustafsson JT, Gunnarsson I, Zickert A, Elvin K, Jensen-Urstad K, Bengtsson A, Gullstrand B, Fredrikson GN, Nilsson J.

Atherosclerosis. 2018 Mar;270:1-7. doi: 10.1016/j.atherosclerosis.2018.01.022. Epub 2018 Jan 17.

PMID:
29407876
35.

High reactivity of deep biota under anthropogenic CO2 injection into basalt.

Trias R, Ménez B, le Campion P, Zivanovic Y, Lecourt L, Lecoeuvre A, Schmitt-Kopplin P, Uhl J, Gislason SR, Alfreðsson HA, Mesfin KG, Snæbjörnsdóttir SÓ, Aradóttir ES, Gunnarsson I, Matter JM, Stute M, Oelkers EH, Gérard E.

Nat Commun. 2017 Oct 20;8(1):1063. doi: 10.1038/s41467-017-01288-8.

36.

Depressed serum IgM levels in SLE are restricted to defined subgroups.

Grönwall C, Hardt U, Gustafsson JT, Elvin K, Jensen-Urstad K, Kvarnström M, Grosso G, Rönnelid J, Padykov L, Gunnarsson I, Silverman GJ, Svenungsson E.

Clin Immunol. 2017 Oct;183:304-315. doi: 10.1016/j.clim.2017.09.013. Epub 2017 Sep 15.

PMID:
28919518
37.

Multivariate strategy for the sample selection and integration of multi-batch data in metabolomics.

Surowiec I, Johansson E, Torell F, Idborg H, Gunnarsson I, Svenungsson E, Jakobsson PJ, Trygg J.

Metabolomics. 2017;13(10):114. doi: 10.1007/s11306-017-1248-1. Epub 2017 Aug 24.

38.

Novel risk genes for systemic lupus erythematosus predicted by random forest classification.

Almlöf JC, Alexsson A, Imgenberg-Kreuz J, Sylwan L, Bäcklin C, Leonard D, Nordmark G, Tandre K, Eloranta ML, Padyukov L, Bengtsson C, Jönsen A, Dahlqvist SR, Sjöwall C, Bengtsson AA, Gunnarsson I, Svenungsson E, Rönnblom L, Sandling JK, Syvänen AC.

Sci Rep. 2017 Jul 24;7(1):6236. doi: 10.1038/s41598-017-06516-1.

39.

Transancestral mapping and genetic load in systemic lupus erythematosus.

Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, Baca V, Bengtsson AA, Berbotto GA, Bijl M, Brown EE, Brunner HI, Cardiel MH, Catoggio L, Cervera R, Cucho-Venegas JM, Dahlqvist SR, D'Alfonso S, Da Silva BM, de la Rúa Figueroa I, Doria A, Edberg JC, Endreffy E, Esquivel-Valerio JA, Fortin PR, Freedman BI, Frostegård J, García MA, de la Torre IG, Gilkeson GS, Gladman DD, Gunnarsson I, Guthridge JM, Huggins JL, James JA, Kallenberg CGM, Kamen DL, Karp DR, Kaufman KM, Kottyan LC, Kovács L, Laustrup H, Lauwerys BR, Li QZ, Maradiaga-Ceceña MA, Martín J, McCune JM, McWilliams DR, Merrill JT, Miranda P, Moctezuma JF, Nath SK, Niewold TB, Orozco L, Ortego-Centeno N, Petri M, Pineau CA, Pons-Estel BA, Pope J, Raj P, Ramsey-Goldman R, Reveille JD, Russell LP, Sabio JM, Aguilar-Salinas CA, Scherbarth HR, Scorza R, Seldin MF, Sjöwall C, Svenungsson E, Thompson SD, Toloza SMA, Truedsson L, Tusié-Luna T, Vasconcelos C, Vilá LM, Wallace DJ, Weisman MH, Wither JE, Bhangale T, Oksenberg JR, Rioux JD, Gregersen PK, Syvänen AC, Rönnblom L, Criswell LA, Jacob CO, Sivils KL, Tsao BP, Schanberg LE, Behrens TW, Silverman ED, Alarcón-Riquelme ME, Kimberly RP, Harley JB, Wakeland EK, Graham RR, Gaffney PM, Vyse TJ.

Nat Commun. 2017 Jul 17;8:16021. doi: 10.1038/ncomms16021.

40.

Altered β2 -glycoprotein I expression on microparticles in the presence of antiphospholipid antibodies.

Mobarrez F, Gunnarsson I, Svenungsson E.

J Thromb Haemost. 2017 Sep;15(9):1799-1806. doi: 10.1111/jth.13765. Epub 2017 Aug 17.

41.

IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE).

Oke V, Brauner S, Larsson A, Gustafsson J, Zickert A, Gunnarsson I, Svenungsson E.

Arthritis Res Ther. 2017 Jun 15;19(1):139. doi: 10.1186/s13075-017-1344-7.

42.

A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus.

Olsson LM, Johansson ÅC, Gullstrand B, Jönsen A, Saevarsdottir S, Rönnblom L, Leonard D, Wetterö J, Sjöwall C, Svenungsson E, Gunnarsson I, Bengtsson AA, Holmdahl R.

Ann Rheum Dis. 2017 Sep;76(9):1607-1613. doi: 10.1136/annrheumdis-2017-211287. Epub 2017 Jun 12.

PMID:
28606963
43.

Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.

Gustafsson JT, Herlitz Lindberg M, Gunnarsson I, Pettersson S, Elvin K, Öhrvik J, Larsson A, Jensen-Urstad K, Svenungsson E.

PLoS One. 2017 Apr 17;12(4):e0174572. doi: 10.1371/journal.pone.0174572. eCollection 2017.

44.

A comparison of patients' and physicians' assessments of disease activity using the Swedish version of the Systemic Lupus Activity Questionnaire.

Pettersson S, Svenungsson E, Gustafsson J, Möller S, Gunnarsson I, Welin Henriksson E.

Scand J Rheumatol. 2017 Nov;46(6):474-483. doi: 10.1080/03009742.2016.1276959. Epub 2017 Mar 15.

PMID:
28293972
45.

Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus.

Parodis I, Sjöwall C, Jönsen A, Ramsköld D, Zickert A, Frodlund M, Sohrabian A, Arnaud L, Rönnelid J, Malmström V, Bengtsson AA, Gunnarsson I.

Autoimmun Rev. 2017 Apr;16(4):343-351. doi: 10.1016/j.autrev.2017.02.005. Epub 2017 Feb 13. Review.

PMID:
28216072
46.

Cross-cultural validation of Lupus Impact Tracker in five European clinical practice settings.

Schneider M, Mosca M, Pego-Reigosa JM, Gunnarsson I, Maurel F, Garofano A, Perna A, Porcasi R, Devilliers H.

Rheumatology (Oxford). 2017 May 1;56(5):818-828. doi: 10.1093/rheumatology/kew492.

PMID:
28204765
47.

Effect of Corticosteroids and Cyclophosphamide on Sex Hormone Profiles in Male Patients With Systemic Lupus Erythematosus or Systemic Sclerosis.

Arnaud L, Nordin A, Lundholm H, Svenungsson E, Hellbacher E, Wikner J, Zickert A, Gunnarsson I.

Arthritis Rheumatol. 2017 Jun;69(6):1272-1279. doi: 10.1002/art.40057. Epub 2017 May 4.

48.

Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional study.

Checa A, Idborg H, Zandian A, Sar DG, Surowiec I, Trygg J, Svenungsson E, Jakobsson PJ, Nilsson P, Gunnarsson I, Wheelock CE.

Lupus. 2017 Sep;26(10):1023-1033. doi: 10.1177/0961203316686707. Epub 2017 Jan 29.

PMID:
28134039
49.

Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis.

Parodis I, Ding H, Zickert A, Arnaud L, Larsson A, Svenungsson E, Mohan C, Gunnarsson I.

Scand J Rheumatol. 2017 Jul;46(4):263-272. doi: 10.1080/03009742.2016.1231339. Epub 2016 Dec 15.

PMID:
27973968
50.

Interferon (IFN)-λ is a potential mediator in lupus nephritis.

Zickert A, Oke V, Parodis I, Svenungsson E, Sundström Y, Gunnarsson I.

Lupus Sci Med. 2016 Nov 22;3(1):e000170. eCollection 2016.

Supplemental Content

Loading ...
Support Center